EXHIBIT 10.4
Addendum No. 3 to Master Lease Agreement
Dated as of September 19, 1996
This Addendum amends and supplements the above-referenced Master Lease
Agreement ("the Lease") by and between General Electric Capital Corporation as
Lessor and Millennium Pharmaceuticals, Inc. as Lessee and is hereby incorporated
into the Lease as though fully set forth therein. All terms not otherwise
defined herein shall have the meanings ascribed to them in the Lease.
The parties hereto agree that Section XXI(a)(iv) of the Lease requires
Lessee to maintain a total liabilities to tangible net worth ratio of 1.0:1 or
less. The parties hereto agree that from and after the date hereof, any
convertible subordinated notes due in 2007 or thereafter shall not be considered
part of Lessee's liabilities or tangible net worth and therefore not part of the
calculation of the ratio set forth in Section XXI(a)(iv).
Except as expressly modified hereby, all terms and provisions of the
Lease shall remain in full force and effect. This Addendum is not binding or
effective with respect to the Lease or the Schedules, or the Equipment until
executed on behalf of each of Lessor and Lessee by authorized representatives of
Lessor and Lessee.
This Addendum is binding upon and inures to the benefit of the parties
hereto and their respective successors and assigns.
IN WITNESS WHEREOF, Lessor and Lessee have caused this Addendum to be
executed by their duly authorized representatives as of this 13th day of
January, 2000.
LESSOR: LESSEE:
General Electric Capital Corporation Millennium Pharmaceuticals, Inc.
By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
Title: VP & Sr. Transaction Mgr. Title: VP Finance
Date: 1/13/2000 Date: 1/11/2000